AstraZeneca | Results Presentation Deck | 45 slides · page 28 of 45
Includes revenue breakdown for Ultomiris, Soliris, Strensiq, and others; regional breakdown; and C5 franchise indication mix.
Conference presentation · kpi_overview · analyze_data · overcrowded density
Slide locked Sign in to view
Slide schematic 9/9
chart 3/3 disclaimer 1/1 list 3/3 title 2/2
Components 9
bar-stacked bar-stacked donut disclaimer bullet bullet bullet action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.